Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia.

Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia. Cancer. 2009 Jan 15; 115(2):373-80.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Antibodies, Neoplasm
Antineoplastic Combined Chemotherapy Protocols
Chromosome Deletion
Chromosomes, Human, Pair 11
Female
Humans
Immunologic Factors
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Rituximab
Survival Rate

authors with profiles

HAGOP M KANTARJIAN
APOSTOLIA MARIA TSIMBERIDOU
WILLIAM G WIERDA